Prognostic factors for hypopharyngeal cancer: a univariate and multivariate study of 142 cases

Acta Otolaryngol Suppl. 2007 Dec:(559):136-44. doi: 10.1080/03655230701600095.

Abstract

Conclusions: Reduction of distant metastases is essential for better survival. Effective adjuvant chemotherapy should be developed for patients with advanced primary disease (T>2) as well as for patients with advanced nodal status (N>0 or PLN>2).

Objectives: The aim of this study was to identify prognostic factors for hypopharyngeal cancer.

Patients and methods: In all, 142 previously untreated patients were analyzed retrospectively; 75% of the cases were stage III or IV. Surgical resection was administered as primary treatment to 116 of the patients (82%), while 26 patients (18%) underwent primary radiotherapy.

Results: The cause-specific 5-year actuarial survival was 46.3%. Distant metastases were the most frequent (23%) cause of failure, followed by local recurrence (15%), and regional recurrence (13%). Cox's regression analysis showed that the significant factors affecting cause-specific survival were N classification, T classification, number of pathological lymph node metastases (PLN), lymphatic invasion, and positive surgical margin. Similarly, T classification and PLN affected distant metastases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / therapeutic use
  • Carcinoma, Squamous Cell / drug therapy
  • Carcinoma, Squamous Cell / pathology*
  • Carcinoma, Squamous Cell / surgery
  • Chemotherapy, Adjuvant
  • Combined Modality Therapy
  • Female
  • Humans
  • Hypopharyngeal Neoplasms / drug therapy
  • Hypopharyngeal Neoplasms / pathology*
  • Hypopharyngeal Neoplasms / surgery
  • Laryngectomy
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Neoplasm Staging
  • Pharyngectomy
  • Prognosis
  • Retrospective Studies

Substances

  • Antineoplastic Agents